Toward new classification criteria for mild and moderate TBI by a data-inclusive cross-study analysis using FITBIR
Toward new classification criteria for mild and moderate TBI by a data-inclusive cross-study analysis using FITBIR
批准号:
9320986
负责人:
Jing Li
金额:
$18.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-22 至 2019-06-30
关键词:
AcuteBig DataCategoriesCause of DeathCessation of lifeCharacteristicsClassificationClinicalClinical TrialsCognitiveCollectionCommon Data ElementDataData CollectionData ElementData SetDescriptorDevelopmentDiagnosticEmergency department visitEnsureEquationEvaluationExclusion CriteriaFutureHeterogeneityHospitalizationImageImpairmentIndividualInjuryInvestigationLeadMeasurementMedicalMedical HistoryMental disordersMeta-AnalysisMethodsModelingNeurologic SymptomsOutcomeOutcome MeasurePatient-Focused OutcomesPatientsPopulationRehabilitation therapyReproducibility of ResultsResearchResearch PersonnelSample SizeSeveritiesSigns and SymptomsSubgroupSupervisionSymptomsSystemTBI PatientsTimeTrainingTraumatic Brain InjuryTreatment EffectivenessUnited StatesWorkaggressive therapybasedemographicsdisabilityeffective therapyexperienceflexibilityfunctional outcomeshigh dimensionalityimprovedinclusion criteriaindividual patientinsightmild traumatic brain injurynervous system disorderoutcome predictionpersonalized medicinepreventprognosticpsychologicsecondary analysissocialtreatment effecttreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Traumatic brain injury (TBI) is amongst the leading causes of death and disability in the United States and
Worldwide. Each year in the United States, there are an estimated 1.7 million TBIs, resulting in 52,000 deaths,
275,000 hospitalizations, and 1,365,000 Emergency Department visits. These TBIs result in substantial
negative impact to many individuals with TBI. Currently, there are not treatments that can be delivered in the
acute post-injury time period that have been shown to result in improved patient outcomes. There is an
undeniable need for effective treatments for patients with TBI who are likely to develop prolonged post-TBI
deficits. A major shortcoming in the TBI field is the inability to accurately classify a patient with TBI according to
that patients expected outcomes. Current classification systems use broad criteria to assign patients to “mild”,
“moderate” or “severe” TBI categories. However, these criteria often allow for patients who are very different
from one another, who have had very different injuries, and who have very different post-injury signs and
symptoms, to be classified into the same TBI group. Current classification results in patients who are classified
the same, e.g. as “mild” TBI, to have substantially variable outcomes. Our research, a secondary analysis of
large datasets contained within FITBIR, aims to develop a more precise classification system for patients who
have experienced a TBI that correlates with expected patient outcomes. To make the classification system
practical for use by clinicians and researchers, data that are typically available at the time of the initial patient
evaluation will be utilized. Factors that might be predictive of patient outcomes and will thus be considered for
inclusion in the refined classification system relate to neurologic symptoms immediately following TBI, findings
at the initial medical evaluation, presence and characteristics of prior TBIs, history of medical, neurologic, and
psychiatric disorders, mechanism of TBI, and patient socio-demographics. The more precise TBI classification
system that will result from this research will inform clinicians on how aggressively to prescribe rehabilitative
therapies, will allow for more accurate prognostication of patient outcomes, and will help to determine inclusion
and exclusion criteria for future clinical trials of TBI therapies.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Sub-classifying patients with mild traumatic brain injury: A clustering approach based on baseline clinical characteristics and 90-day and 180-day outcomes.
对轻度创伤性脑损伤患者进行细分:基于基线临床特征以及 90 天和 180 天结果的聚类方法。
DOI:
10.1371/journal.pone.0198741
发表时间:
2018
期刊:
PloS one
影响因子:
3.7
作者:
[Si,Bing, Dumkrieger,Gina, Wu,Teresa, Zafonte,Ross, Valadka,AlexB, Okonkwo,DavidO, Manley,GeoffreyT, Wang,Lujia, Dodick,DavidW, Schwedt,ToddJ, Li,Jing]
通讯作者:
Li,Jing
AIDen: An AI-empowered detection and diagnosis system for jaw lesions using CBCT
-
批准号:10383494
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2022
-
负责人:Jing Li
-
依托单位:
Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors
-
批准号:10674753
-
项目类别:
-
资助金额:$36.94万
-
财政年份:2021
-
负责人:Jing Li
-
依托单位:
Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors
-
批准号:10459595
-
项目类别:
-
资助金额:$37.32万
-
财政年份:2021
-
负责人:Jing Li
-
依托单位:
Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors
-
批准号:10298016
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2021
-
负责人:Jing Li
-
依托单位:
Effect of Medicare Reimbursement for Care Planning on End of Life Care among Patients with Alzheimer's Disease and Related Dementias: A Quasi-Experimental Study
-
批准号:10172824
-
项目类别:
-
资助金额:$12.58万
-
财政年份:2020
-
负责人:Jing Li
-
依托单位:
Effect of Medicare Reimbursement for Care Planning on End of Life Care among Patients with Alzheimer's Disease and Related Dementias: A Quasi-Experimental Study
-
批准号:10677882
-
项目类别:
-
资助金额:$12.81万
-
财政年份:2020
-
负责人:Jing Li
-
依托单位:
Effect of Medicare Reimbursement for Care Planning on End of Life Care among Patients with Alzheimer's Disease and Related Dementias: A Quasi-Experimental Study
-
批准号:10408777
-
项目类别:
-
资助金额:$0.92万
-
财政年份:2020
-
负责人:Jing Li
-
依托单位:
Effect of Medicare Reimbursement for Care Planning on End of Life Care among Patients with Alzheimer's Disease and Related Dementias: A Quasi-Experimental Study
-
批准号:10690298
-
项目类别:
-
资助金额:$11.6万
-
财政年份:2020
-
负责人:Jing Li
-
依托单位:
Impact of the Physician Payments Sunshine Act on Prescription Drug Utilization and Spending
-
批准号:9807060
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2019
-
负责人:Jing Li
-
依托单位:
Project MISSION: Developing a multicomponent, Multilevel Implementation Strategy for Syncope OptImalCare thrOugh eNgagement
-
批准号:9755244
-
项目类别:
-
资助金额:$50.94万
-
财政年份:2018
-
负责人:Jing Li
-
依托单位:
Development of nucleic acid delivery platform based on polymeric CXCR4 antagonists
-
批准号:9045744
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2016
-
负责人:Jing Li
-
依托单位:
Multi-Modality Image Data Fusion and Machine Learning Approaches for Personalized Diagnostics and Prognostics of MCI due to AD
-
批准号:10264079
-
项目类别:
-
资助金额:$121.97万
-
财政年份:2016
-
负责人:Jing Li
-
依托单位:
Pharmacology
-
批准号:8350775
-
项目类别:
-
资助金额:$4.34万
-
财政年份:2011
-
负责人:Jing Li
-
依托单位:
Multi-point and multi-locus analysis of genomic association data
-
批准号:7897811
-
项目类别:
-
资助金额:$93.03万
-
财政年份:2006
-
负责人:Jing Li
-
依托单位:
Efficient Analysis of SNPs & Haplotypes with Applications in Gene Mapping
-
批准号:7020438
-
项目类别:
-
资助金额:$42.28万
-
财政年份:2006
-
负责人:Jing Li
-
依托单位:
Efficient Analysis of SNPs & Haplotypes with Applications in Gene Mapping
-
批准号:7209009
-
项目类别:
-
资助金额:$39.39万
-
财政年份:2006
-
负责人:Jing Li
-
依托单位:
Multi-point and multi-locus analysis of genomic association data
-
批准号:7652746
-
项目类别:
-
资助金额:$95.1万
-
财政年份:2006
-
负责人:Jing Li
-
依托单位:
Pharmacology
-
批准号:8600867
-
项目类别:
-
资助金额:$4.63万
-
财政年份:--
-
负责人:Jing Li
-
依托单位:
Shared Resource: Pharmacology
-
批准号:8997280
-
项目类别:
-
资助金额:$7.69万
-
财政年份:--
-
负责人:Jing Li
-
依托单位:
Pharmacology
-
批准号:8780610
-
项目类别:
-
资助金额:$4.51万
-
财政年份:--
-
负责人:Jing Li
-
依托单位:
国内基金
海外基金
Scalable Learning and Optimization: High-dimensional Models and Online Decision-Making Strategies for Big Data Analysis
-
批准号:--
-
项目类别:合作创新研究团队
-
资助金额:--
-
批准年份:2024
-
负责人:姚韬
-
依托单位: